Vaccine & Biologics Cold Chain Shipping: Requirements for India Exporters

A temperature excursion can put an entire pharmaceutical shipment at risk. For an Indian exporter, the challenge is not simply keeping vaccines or biologics cold; it is maintaining the approved storage conditions, documentation, packaging controls, and shipment records throughout the journey.

Vaccine cold chain shipping in India requires a coordinated process covering product-specific temperature requirements, qualified packaging, monitoring, handling, customs documentation, and regulatory compliance. Most vaccines used in immunisation programmes are traditionally stored and distributed at 2°C to 8°C, but some products require frozen or ultra-cold conditions. The correct range must always be determined from the product’s approved requirements rather than assumed.

For exporters handling vaccines and biologics, cold chain planning should begin before the shipment is booked. A suitable temperature-controlled packaging solution, validated handling process, and complete export documentation can help protect product quality while reducing the risk of delays.

Key Takeaways:

• Confirm the product-specific temperature range before planning the shipment.
• Use qualified temperature-controlled packaging suited to the route and transit time.
• Monitor and document temperature conditions throughout the shipment.
• Prepare Indian export, CDSCO, and destination-country documentation in advance.
• Coordinate customs clearance early to minimise delays and cold-chain risks.

Why Vaccine and Biologics Exports Need Special Handling

Vaccines and other biological products can be sensitive to temperature changes, making ordinary freight processes unsuitable for many shipments. WHO notes that vaccines can lose effectiveness or become unusable when exposed to inappropriate temperatures, while different vaccines can have different storage requirements.

That means you cannot select packaging simply because it is described as a “cold chain”. You need to know the product’s approved temperature range, permitted excursion limits, expected transit duration, and handling conditions before selecting the shipping solution.

This is particularly important for biologics export logistics involving pharmaceutical and healthcare products, where the shipment may involve multiple handovers between the manufacturing site, temperature-controlled storage, airport facilities, carriers, customs authorities and the overseas consignee.

WHO’s 2025 international vaccine shipping guidance specifically addresses the challenges involved in maintaining required temperatures throughout international transportation and applies to manufacturers, logistics providers, freight forwarders, carriers and other parties involved in the shipment.

For exporters, the practical takeaway is simple: cold chain should be treated as a complete logistics process, not just a packaging decision.

Start With the Product’s Approved Temperature Range

The first step in vaccine shipping compliance in India is identifying the exact temperature conditions applicable to the product being exported.

Do not assume that every vaccine or biologic must remain at 2°C to 8°C. WHO states that most vaccines used in immunisation programmes are licensed for the traditional 2°C to 8°C cold chain, while some products require different conditions.

For example, WHO’s prequalification information for a currently listed measles vaccine manufactured in India specifies storage at 2°C to 8°C. Other vaccines may have different approved conditions, including frozen or ultra-cold storage.

Before arranging transportation, confirm:

• Approved storage temperature
• Permitted temperature excursions
• Maximum transit duration
• Product shelf life
• Packaging requirements
• Handling instructions
• Temperature-monitoring requirements
• Any destination-specific conditions

This information should come from the product’s approved documentation and applicable regulatory requirements.

Why Product-Specific Planning Matters

A shipment can remain physically cold and still be unsuitable if the temperature falls outside the product’s permitted range. For example, a product requiring refrigerated conditions should not automatically be frozen simply because lower temperatures appear safer.

The same principle applies to biologics. Product stability can differ substantially, so the logistics plan must be based on the specific product rather than a generic pharma shipping template.

Choosing Temperature-Controlled Packaging

Temperature-controlled packaging is one of the most important components of cold chain transport. The packaging system should be appropriate for the required temperature range, shipment duration, external conditions, and handling environment.

WHO’s international vaccine shipping guidance highlights the need to maintain required temperatures during international transport and refers to the use of suitable packaging and qualified refrigerated transport where applicable.

Depending on the product and validated shipping method, exporters may use:

• Insulated passive packaging systems
• Refrigerated containers
• Temperature-controlled vehicles
• Dry ice-based systems
• Phase-change material systems
• Qualified thermal shippers
• Active temperature-controlled units

The correct choice depends on the product’s requirements and the validated shipping configuration.

1. Packaging Is More Than Insulation

A cold-chain package must be designed around the shipment’s entire journey.

Consider:

• Transit duration: How long will the shipment remain outside controlled storage?
• Ambient exposure: What temperatures could the package encounter during loading, road transport, airport handling, or customs procedures?
• Thermal performance: Can the packaging maintain the required range for the expected duration?
• Handling: Can the packaging withstand normal movement and handling without compromising product protection?
• Monitoring: Can temperature data be recorded throughout the relevant part of the journey?

2. Temperature Monitoring and Data Records

Maintaining the correct temperature is only part of the requirement. You also need evidence that the required conditions were maintained.

Temperature monitoring devices can record conditions during transport and provide data that can be reviewed when the shipment arrives.

Your cold chain plan should establish:

• Where temperature will be monitored
• What monitoring device will be used
• How the device will be activated
• Who will review the data
• What constitutes a temperature excursion
• What happens if an excursion occurs
• How records will be retained

For vaccine shipments, WHO guidance emphasises temperature monitoring and appropriate procedures when consignments are received.

If an excursion occurs, do not automatically assume that the shipment is either safe or unusable. Product-specific stability information and the applicable quality procedure should determine the assessment and disposition.

Packaging Qualification and Temperature Mapping

Cold chain packaging should be selected based on evidence that it can maintain the required conditions under expected shipping conditions.

Temperature mapping is used to understand temperature distribution within storage areas and equipment. WHO describes temperature mapping as integral to appropriate pharmaceutical storage and notes that good manufacturing practice recommends regular mapping of warehouses and cold chain equipment.

For exporters, this principle supports a broader approach: the temperature-control process should be documented and supported by appropriate qualification and monitoring.

Before using a packaging configuration, consider:

• Product temperature range
• Shipment duration
• Seasonal ambient conditions
• Route characteristics
• Number of handling points
• Packaging configuration
• Cooling material
• Temperature-monitoring arrangement

A packaging solution that performs well in one route or season may require reassessment for another operating environment.

Regulatory and Export Documentation for Indian Shipments

Temperature control does not replace standard export compliance. Your shipment also needs the documentation required for exporting goods from India and any additional documents applicable to regulated pharmaceutical or biological products.

The Directorate General of Foreign Trade states that mandatory export documents include the transport document, commercial invoice-cum-packing list, and Shipping Bill/Bill of Export, while additional documentation may apply to specific goods subject to restrictions, policy conditions, NOCs, or product-specific requirements.

For a vaccine or biologic export, the documentation package may therefore include, depending on the shipment:

• Commercial invoice
• Packing list
• Shipping Bill
• Air Waybill or other transport document
• Certificate of Origin, where required
• Product and batch information
• Certificate of Analysis, where applicable
• Regulatory certificates or permissions
• Export NOC, where applicable
• Temperature and handling records
• Insurance documentation
• Import-country permits or approvals

The exact requirements depend on the product, destination, regulatory status, and purpose of export. Understanding Incoterms 2020 can also help exporters clarify responsibilities for transportation, insurance, customs, and delivery.

CDSCO Requirements Matter

India’s Central Drugs Standard Control Organization (CDSCO) regulates vaccines and biological products under the applicable pharmaceutical framework. Its biological resources include vaccine-related regulatory guidance and procedures, including provisions relating to export NOCs and permissions for certain biological products.

CDSCO’s vaccine policy also states that vaccines are drugs under the Drugs and Cosmetics Act, 1940, and outlines a regulatory framework covering manufacturers, importers, and exporters.

This means exporters should not treat vaccine shipments as ordinary commercial cargo. Before dispatch, confirm whether the specific product and transaction require a CDSCO-related approval, NOC, certificate, or other regulatory documentation.

Customs Planning Can Protect the Cold Chain

Customs clearance is one of the stages where temperature-sensitive cargo can face avoidable exposure.

A shipment may arrive at the airport on schedule but still experience delays if the paperwork is incomplete, product information is inconsistent, or an approval is missing. For vaccines and biologics, every additional handling or waiting period needs to be considered in the cold-chain plan.

Your customs preparation should therefore begin before the cargo is dispatched.

Check:

• HS classification
• Product description
• Invoice and packing list consistency
• Regulatory approvals
• Import-country requirements
• Shipping documents
• Batch and product details
• Temperature-sensitive handling instructions
• Availability of the consignee or customs representative

For more details on this risk, see pharma cold chain customs delays, which can be used as an internal resource for exporters planning temperature-sensitive shipments.

Building a Cold Chain Plan for India Exporters

A practical cold chain plan should cover the shipment from the manufacturer’s facility to the overseas consignee rather than focusing only on the international flight.

1. Confirm Product Requirements

Start with the approved temperature range, stability information, and handling instructions for the specific product.

2. Map the Route

Identify every major handover, including:

• Factory pickup
• Local transportation
• Cold storage
• Airport handling
• Customs
• Air transport
• Destination handling
• Final delivery

3. Select the Packaging

Choose a qualified temperature-controlled packaging solution appropriate for the required temperature range and expected transit duration.

4. Establish Monitoring

Decide how temperature will be monitored and how records will be reviewed.

5. Prepare Regulatory Documents

Confirm Indian export requirements as well as destination-country requirements before dispatch.

6. Plan for Delays

Build an escalation process for:

• Flight disruptions
• Customs holds
• Extreme weather
• Missed connections
• Packaging issues
• Temperature excursions

7. Define Excursion Procedures

Your quality team should know what information is required to assess a temperature excursion and who has authority to make the final product disposition.

This structured approach reduces the risk of treating the cold chain as a single transport activity. Businesses can also choose a freight forwarder with relevant air cargo and pharmaceutical handling experience to coordinate carriers, documentation, and temperature-sensitive shipments.

Common Mistakes to Avoid in Vaccine Cold Chain Shipping

Even well-planned shipments can encounter problems when exporters overlook operational details.

1. Assuming All Vaccines Need the Same Temperature

Product-specific requirements must always take priority. While 2°C to 8°C is common, it is not universal.

2. Choosing Packaging Based Only on Cost

The cheapest packaging option may not provide the required protection for the route or transit duration. Evaluate the complete shipping profile before selecting a system.

3. Treating Customs as a Separate Process

A customs hold can become a cold-chain problem. Customs planning should therefore form part of the temperature-control strategy. Avoiding common customs clearance mistakes is particularly important when delays can place temperature-sensitive products under additional cold-chain pressure.

4. Not Reviewing Temperature Data

A temperature logger is useful only when someone reviews the data and follows the established excursion procedure.

5. Using Generic Documentation

Pharmaceutical and biological exports may require product-specific regulatory documentation. Confirm requirements for each shipment rather than relying on a previous consignment’s paperwork.

Why GDP Compliance Matters for Pharma Cold Chain

Good Distribution Practice provides a framework for protecting pharmaceutical products throughout storage and distribution. WHO guidance identifies storage and transportation as areas where medical products can face risks and emphasises appropriate systems for maintaining product quality across the supply chain.

For Indian exporters, GDP-aligned processes can help create consistency across:

• Storage
• Transportation
• Temperature monitoring
• Documentation
• Handling
• Quality management
• Deviation management

You can also refer to GDP Compliance for Pharma Exports for a broader look at good distribution practices and how they apply to international pharmaceutical logistics.

The goal is not simply to move a shipment from India to another country. It is to maintain product integrity and traceability throughout the distribution process.

Conclusion

Vaccine cold-chain shipping in India requires coordination across product requirements, packaging, temperature monitoring, customs preparation, and regulatory compliance. The appropriate temperature cannot be inferred from the product category alone; it must be determined by the specific vaccine or biologic’s approved requirements.

For Indian exporters, the safest approach is to plan the cold chain before dispatch, select qualified temperature-controlled packaging, maintain reliable temperature records, and prepare export and regulatory documentation in advance.

Because vaccines and biologics can be sensitive to temperature excursions and delays, cold chain logistics should be managed as an integrated process from origin through final delivery.

Planning a vaccine or biologics export from India? Speak with our team to discuss your shipment’s temperature, documentation, customs, and international logistics requirements before dispatch.

Frequently Asked Questions